Identification of candidates for postmastectomy radiotherapy in patients with pT3N0M0 breast cancer

ISSN： 1340-6868

Source： Breast Cancer, Vol.20, Iss.3, 2013-07, pp. : 218-222

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Should adjuvant trastuzumab be offered in very early-stage (pT1a/bN0M0) HER2- neu -positive breast cancer? A current debate

By Petrelli Fausto

Medical Oncology, Vol. 28, Iss. 2, 2011-06 ,pp. : 401-408

Humana Press, Inc

Access to resources Recommend Favorite

Prognostic Value of Quantitative Cytometry in a Series of 415 T1T2/N0N1/M0 Breast Cancer Patients--Preliminary Results

By Bolla M. Seigneurin D. Winckel P. Marron-Charriere J. Panh M.H. Pasquier D. Chedin M. Payan R. Merlin F. Colonna M.

European Journal of Cancer, Vol. 32, Iss. 10, 1996-09 ,pp. : 1680-1685

Elsevier

Access to resources Recommend Favorite

Stereotactic hypofractionated radiotherapy in stage I (T1-2 N0 M0) non-small-cell lung cancer (NSCLC)

By Zimmermann Frank Geinitz Hans Schill Sabine Thamm Reinhard Nieder Carsten Schratzenstaller Ulrich Molls Michael

Acta Oncologica, Vol. 45, Iss. 7, 2006-09 ,pp. : 796-801

Informa Healthcare

Access to resources Recommend Favorite

Treatment Trends and Factors Associated with Survival in T1aN0 and T1bN0 Breast Cancer Patients

By Kennedy Timothy

Annals of Surgical Oncology, Vol. 14, Iss. 10, 2007-10 ,pp. : 2918-2927

Springer Publishing Company

Access to resources Recommend Favorite

Present-Day Locoregional Control in Patients with T1 or T2 Breast Cancer with 0 and 1 to 3 Positive Lymph Nodes After Mastectomy Without Radiotherapy

By Sharma Ranjna

Annals of Surgical Oncology, Vol. 17, Iss. 11, 2010-11 ,pp. : 2899-2908

Springer Publishing Company

Access to resources Recommend Favorite